RAD18 polymorphisms are associated with platinum-based chemotherapy toxicity in Chinese patients with non-small cell lung cancer

被引：0
|
作者：
Tian-qing Chu
Rong Li
Min-hua Shao
Jun-yi Ye
Bao-hui Han
机构：
[1] Shanghai Chest Hospital,Department of Pulmonary Medicine
[2] Shanghai Jiao Tong University,undefined
[3] Institutes of Biomedical Sciences,undefined
[4] Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
NSCLC; platinum-based chemotherapy; polymorphisms; gastrointestinal toxicity; hematological toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1490 / 1498
页数：8
相关论文
共 50 条
  • [41] Pol ζ polymorphisms are associated with platinum based chemotherapy response and side effects among non-small cell lung cancer patients
    Ye, J.
    Chu, T.
    Li, R.
    Niu, Y.
    Jin, B.
    Xia, J.
    Shao, M.
    Han, B.
    NEOPLASMA, 2015, 62 (05) : 833 - 839
  • [42] Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients
    Qian, Lei
    Ding, Xiao
    Li, Fang-Qi
    Tian, Hui-Min
    Chen, Xiao
    Han, Fu-Jun
    Wang, Hong-Yi
    Li, Wen-Qian
    Niu, Chao
    Xu, Jian-Ting
    Li, Zhao-Zhi
    He, Hua
    Cui, Jiu-Wei
    NEOPLASMA, 2023, 70 (02) : 251 - 259
  • [43] DECREASE OF CIRCULATING TUMOR CELLS ASSOCIATES WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER, BUT NOT WITH SMALL CELL LUNG CANCER
    Gauler, Thomas C.
    Theegarten, Dirk
    Parr, Annette
    Schuhr, Ivonne
    Schmid, Kurt W.
    Eberhardt, Wilfried
    Schuler, Martin
    Hoffmann, Andreas-Claudius
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1114 - S1114
  • [44] PLATINUM-BASED COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CARCINOMA
    TAKITA, H
    EDGERTON, F
    MARABELLA, P
    CONWAY, D
    HARGUINDEY, S
    CANCER, 1981, 48 (07) : 1528 - 1530
  • [45] Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer
    Wan Zhao
    Lingmin Hu
    Jiali Xu
    Hongbing Shen
    Zhibin Hu
    Hongxia Ma
    Yongqian Shu
    Yongfeng Shao
    Yongmei Yin
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1287 - 1295
  • [46] Genetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancer
    Hu, Weicai
    Pan, Jinbing
    Zhao, Pu
    Yang, Guangyu
    Yang, Shujuan
    TUMOR BIOLOGY, 2014, 35 (06) : 5561 - 5567
  • [47] Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients
    Perez-Ramirez, Cristina
    Canadas-Garre, Marisa
    Alnatsha, Ahmed
    Villar, Eduardo
    Valdivia-Bautista, Javier
    Jose Faus-Dader, Maria
    Angel Calleja-Hernandez, Miguel
    PHARMACOGENOMICS JOURNAL, 2019, 19 (02): : 164 - 177
  • [48] Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients
    Zhao, Xin
    Zhang, Zhiqiang
    Yuan, Yan
    Yuan, Xiaomei
    TUMOR BIOLOGY, 2014, 35 (08) : 8335 - 8341
  • [49] Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients
    Cristina Pérez-Ramírez
    Marisa Cañadas-Garre
    Ahmed Alnatsha
    Eduardo Villar
    Javier Valdivia-Bautista
    María José Faus-Dáder
    Miguel Ángel Calleja-Hernández
    The Pharmacogenomics Journal, 2019, 19 : 164 - 177
  • [50] Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer
    Zhao, Wan
    Hu, Lingmin
    Xu, Jiali
    Shen, Hongbing
    Hu, Zhibin
    Ma, Hongxia
    Shu, Yongqian
    Shao, Yongfeng
    Yin, Yongmei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1287 - 1295
12345